Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Allele Traits01:49

Multiple Allele Traits

35.1K
The Concept of Multiple Allelism
35.1K
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

31
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
31
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

73
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
73
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

59
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
59

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Granular soil densification using expansive resins.

Scientific reports·2026
Same author

The evolution of therapy for chronic osteoarthritic knee pain: Feasibility, safety and clinical outcomes of transpedal access for genicular artery embolization.

European journal of radiology·2026
Same author

Risk of thrombosis with thrombocytopaenia syndrome (TTS) after vaccination with AZD1222: a European VAC4EU post-authorisation safety study.

Vaccine·2026
Same author

Optometrist attitudes towards delivering intravitreal injections in Aotearoa New Zealand.

Clinical & experimental optometry·2026
Same author

Microbiome education at under-resourced institutions: current status, barriers, and approaches to successful implementation.

Journal of microbiology & biology education·2026
Same author

Trajectory of weight regain after cessation of GLP-1 receptor agonists: a systematic review and nonlinear meta-regression.

EClinicalMedicine·2026

Related Experiment Video

Updated: Sep 24, 2025

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.8K

Hepatic Infarction in a Patient With Sickle Cell Trait Presenting With HELLP Syndrome.

Anish C Paudel1, John F Altomare2, Oluwaseun Shogbesan2

  • 1Internal Medicine, The Reading Hospital, West Reading, USA.

Cureus
|May 4, 2022
PubMed
Summary

Hepatic infarction is a rare complication of HELLP syndrome in pregnancy. This case highlights the potential role of sickle cell trait in potentiating liver infarction alongside pre-eclampsia.

Keywords:
elevated liver enzymeshellp syndromehepatic infarctionpreeclampsiasickle cell trait

More Related Videos

Method of Direct Segmental Intra-hepatic Delivery Using a Rat Liver Hilar Clamp Model
09:22

Method of Direct Segmental Intra-hepatic Delivery Using a Rat Liver Hilar Clamp Model

Published on: April 2, 2017

14.3K
Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
08:23

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry

Published on: November 5, 2019

10.0K

Related Experiment Videos

Last Updated: Sep 24, 2025

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.8K
Method of Direct Segmental Intra-hepatic Delivery Using a Rat Liver Hilar Clamp Model
09:22

Method of Direct Segmental Intra-hepatic Delivery Using a Rat Liver Hilar Clamp Model

Published on: April 2, 2017

14.3K
Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
08:23

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry

Published on: November 5, 2019

10.0K

Area of Science:

  • Obstetrics and Gynecology
  • Hepatology
  • Hematology

Background:

  • Hepatic infarction is rare due to dual liver blood supply, often linked to post-transplant complications, surgery, or shock.
  • Hemolysis, elevated liver enzymes, and low platelet (HELLP) syndrome is an obstetric emergency associated with elevated liver enzymes, particularly in pre-eclampsia.
  • Sickle cell disease is known to cause hepatic infarction, but the effect of sickle cell trait is less understood.

Observation:

  • A pregnant patient with underlying sickle cell trait presented with clinical features of HELLP syndrome.
  • Despite prompt cesarean delivery, liver enzymes rose post-operatively, and CT scan confirmed multifocal hepatic infarctions.
  • Pre-eclampsia was a contributing factor due to impaired oxygenation and hepatic hypoperfusion.

Findings:

  • This case demonstrates hepatic infarction as a rare complication of HELLP syndrome in a patient with sickle cell trait.
  • The study suggests pre-eclampsia contributed to hepatic hypoperfusion, potentially exacerbated by sickle cell trait.
  • The role of sickle cell trait in potentiating hepatic infarction requires further investigation.

Implications:

  • This case underscores the importance of considering HELLP syndrome in pregnant patients with elevated liver enzymes, especially with pre-eclampsia.
  • It raises awareness about the potential, though unconfirmed, link between sickle cell trait and hepatic infarction.
  • Further research is needed to clarify the specific risks associated with sickle cell trait regarding hepatic complications.